Oat and treatment of kidney disease

The effect of oat consumption on renal function in subjects with chronic kidney disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015050414551N2

Enrollment

Registered

2015-12-10

Start date

2015-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease. Chronic kidney disease, unspecified

Interventions

Intervention 1: Intervention group: Nutritional recommendations for patients with chronic kidney disease will be delivered to this group. Subjects are also prescribed to consume 50 gr/day oat powder.

Treatment - Other

Intervention group: Nutritional recommendations for patients with chronic kidney disease will be delivered to this group. Subjects are also prescribed to consume 50 gr/day oat powder.

Control group: Nutritional recommendations for patients with chronic kidney disease will be delivered to this group.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: GFR<90 mL/min/1.73m2, without any disease which interpret with study outcomes, no using medications which interpret with study outcomes, fill the written consent Exclusion criteria: low adherence to the prescribed diet, loss to fallow up, start using medications which interpret with study outcomes, get disease which interpret with study outcomes

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood Urea Nitrogen. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Serum Creatinine. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Serum Albumin. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Urine Creatinine. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Urine Protein. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Parathyroid hormone. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Serum Klotho. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Serum Potassium. Timepoint: 8 weeks. Method of measurement: Biochemistry.	—

Measure

Time frame

Blood Urea Nitrogen. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Serum Creatinine. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Serum Albumin. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Urine Creatinine. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Urine Protein. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Parathyroid hormone. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Serum Klotho. Timepoint: 8 weeks. Method of measurement: Biochemistry.;Serum Potassium. Timepoint: 8 weeks. Method of measurement: Biochemistry.

—

Secondary

Measure	Time frame
Weight. Timepoint: 8 Weeks. Method of measurement: Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Leila Azadbakht

Isfahan University of Medical Sciences

Azadbakht@hlth.mui.ac.ir+98 31 3792 3151

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 11, 2026